Abstract
Cancer chemotherapy is the object of many fundamental and clinical researches. The development in molecular techniques and structural studies at the molecular level have led to the discovery of key proteins involved in the regulation of cell proliferation. This opened perspectives to characterize new anticancer drugs in order to reduce the limitations found with conventional drugs such as the lack of selectivity for cancer cells and resistance phenomena. This review presents the anticancer drugs in clinical investigations that target molecules involved in the signal transduction impairment, the cell cycle deregulation and the differentiation with comments on their mechanisms of action.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Gottesman, M.M. and Pastan, I. (1993) Ann. Rev. Biochem. 62, 385–427.
Morgan, D.O. (1995) Nature 374, 131–134.
Meijer, L. (1995) in Progress in Cell Cycle Research (Meijer, L., Guidet, S. and Tung, H.Y.L., eds.) vol. 29, pp 351–363, Plenum Press, New York, NY.
Paulovitch, A.G., Toczyski, D.P. and Hartwell, L.H. (1997) Cell 88, 315–321.
Kelloff, G.J., Fay, J.R., Steele, V.E., Lubet, R.A., Boone, C.W., Crowell, J.A., Sigman, C.C. (1996) Cancer Epidemiol. BiQmarkers Prey. 8, 657–666.
Traxler, P.M. (1997) Exp. Opin. Ther. Patents 7, 571–588.
Traxler, P., Furet, P., Mett, H., Buchdunger, E., Meyer, T., Lydon, N. (1997) J. Pharm. Belg. 52, 88–96.
Shawver, L.K., Schwartz, D.P., Mann, E., Chen, H., Tsai, J., Chu, L., Taylorson, L, Longhi, M., Meredith, S., Germain, L, Jacobs, J.S., Tang, C., Ullrich, A., Berens, M.E., Hersh, E., McMahon, G., Hirth, K.P., Powell, T.J. (1997) Clin. Cancer Res. 7, 1167–1177.
Mason, W., Malkin, M., Liebermann, F., Cropp, G., Hannah, A. (1996) Proc. Am. Assoc. Cancer Res. 37, 166.
Camoratto, A.M., Jani, J.P., Angeles, T.S., Maroney, A.C., Sanders, C.Y., Murakata, C, Neff, N.T., Vaught, J.L., Isaacs, J.T., Dionne, C.A. (1997) Int. J. Cancer 72, 673–679.
Dionne, C.A., Camoratto, A.M., Jani, J.P., Emerson, E., Neff, N., Vaught, J.L., Murakata, C, Djakiew, D., Lamb, J., Bova, S., George, D., Isaacs, J.T. (1998) Clin. Cancer Res. 4, 1887–1898.
Gibbs, J.B. (1991) Cell 65, 1–4.
Zhang, F.L. and Casey, P.J. (1996) Ann. Rev. Biochem. 65, 241–269.
Coleman, P.S., Chen, L.C. and Sepp-Lorenzino, L. (1997) Subcell. Biochem. 28, 363–435.
Gibbs, J.B. and Oliff, A. (1997) Annu. Rev. Pharmacol. Toxicol. 37, 143–166.
James, G.L., Goldstein, J.L., Brown, M.S., Rawson, T.E., Somers, T.C., Mc Dowell, R.S., Crowley, C.W., Lucas, B.K., Levinson, A.D. and Marters, J.C.Jr. (1993) Science 260, 1937–1942.
Khol, N.E., Mosser, S.D., deSolms, S.J., Giuliani, E.A., Pompliano, D.L., Grahams, S.L., Smith, R.L., Scolnick, E.M., Oliff, A. and Gibbs, J.B. (1993) Science, 260, 1934–1937.
Singh, S.B. and Lingham, R.B. (1996) Exp. Opin. Invest. Drugs 5, 1589–1599.
Kohl, N.E., Conner, M.W., Gibbs, J.B., Graham, S.L., Hartman, G.D. and Oliff, A. (1995) J. Cell Biochem. 22, suppl., 145–150.
Sepp-Lorenzino, L., Ma, Z., Rands, E., Kohl, N., Gibbs, J., Oliff, A. and Rosen, N. (1995) Cancer Res. 55, 5302–5309.
Kohl, N.E., Wilson, F.R., Mosser, S.D., Giuliani, E.A., DeSolms, S.J., Conner, M.W., Anthony, N.J., Holtz, W.J., Gomez, R.P., Lee, T.J., Smith, R.L., Graham, S.L., Hartman, G.D., Gibbs, J.B. and Oliff, A. (1994) Proc. Natl. Acad. Sci. USA 91, 9141–9145.
Moasser, M.M., Sepp-Lorenzino, L, Kohl, N.E., Oliff, A., Balog, A., Su, D.S., Danishefsky, S.J. and Rosen, N. (1998) Proc. Natl. Acad. Sci. USA 95, 1369–1374.
Weinberg, R.A. (1989) Cancer Res. 49, 3713–3721.
Nakanishi, H., Brewer, K.A. and Exton, J.H. (1993) J. Biol. Chem. 268, 13–16.
Newton, A.C. (1995) J. Biol. Chem. 270, 28495–28498.
Livneh, E. and Fishman, D.D. (1997) Eur. J. Biochem. 248, 1–9.
Pettit, G.R. (1991) Prog. Chem. Org. Nat. Prod. 57, 153–193.
De Vries, D.J., Herald, C.L., Pettit, G.R. and Blumberg, P.M. (1988) Biochem. Pharmacol. 37, 4069–4073.
Kraft, A.S., Smith, J.B. and Berkow, R.L. (1986) Proc. Natl. Acad. Sci. USA 83, 1334–1338.
Hornung, R.L., Pearson, J.W., Beckwith, M. and Longo, D.L. (1992) Cancer Res. 52, 101–107.
Mohammad, R.M., Diwakaran, H., Maki, A., Emara, M.A., Pettit, G.R., Redman B. and alKatib, A. (1995) Leuk. Res. 19, 667–673.
Maki, A., Diwakaran, H., Redman, B., al-Asfar, S., Pettit, G.R., Mohammad, R.M. and al-Katib, A. (1995) Anticancer Drugs 6, 392–397.
McGrown, A.T., Jayson, G., Pettit, G.R., Haran, M.S., Ward, T.H. and Crowther, D. (1998) Br. J. Cancer 77, 216–220.
Aftab, D.T., Yang, J.M. and Hait, W.N. (1994) Oncol. Res. 6, 59–70.
Chambers, T.C., Patel, J. and Chabner, B.A. (1992) Mol. Pharmacol. 41, 1008–1015.
Utz, I, Hofman, J. and Grunicke, H. (1995) Eur. J. Cancer 31A, 513.
Varterasian, M.L., Mohammad, R.M., Eilender, D.S., Hulburd, K., Rodriguez, D.H., Pemberton, P.A., Pluda, J.M., Dan, M.D., Pettit, G.R., Chen, B.D. and al-Katib, A.M. (1998) J. Clin. Oncol. 16, 56–62.
Grant, S., Roberts, J., Poplin, E., Tombes, M.B., Kyle, B., Welch, D., Carr, M. and Bear, H.D. (1998) Clin. Cancer Res. 4, 611–618.
Hess, A.D., Silankis, M.K., Esa, A.H., Pettit, G.R. and May W.S. (1988) J. Immunol. 141, 3263–3269.
Sharkis, S.J., Jones, R.J. and Bellis, M.L. (1990) Blood 76, 716–720.
Wender, P.A., DeBrabander, J., Harran, P.G., Jimenez, J.M., Koehler, M.F.T., Lippa, B., Park, C.M., Siedenbiedel, C. and Pettit, G.R. (1998) Proc. Natl. Acad. Sci. USA 95, 6624–6629.
Beebe, S.J. and Corbin, J.D. (1986) in The enzymes(Boyer, P.D. and Krebs, E.G.) vol 17, pp 43–111, Academic Press, New York, NY.
Cho-Chung, Y.S. (1990) Cancer Res. 50, 7093–7100.
Cho-Chung, Y.S., Clair, T., Tortora, G., Yokozaki, H. and Pepe, S. (1991) Life Sci. 48, 1123–1132.
Rohlff, C., Clair, T. and Cho-Chung, Y.S. (1993) J. Biol. Chem. 268, 5774–5782.
Ramage, A.D., Langdon, S.P., Ritchie, A.A., Burns, D.J. and Miller W.R. (1995) Eur. J. Cancer 31A, 969–973.
Fassina, G., Aluigi, M.G., Gentleman, S., Wong, P., Cai, T., Albini, A. and Noonan, D.M. (1997) Int. J. Cancer 17, 1088–1094.
Boe, R, Grejtsen, B.T., Doskeland, S.O. and Vintermyr, O.K. (1995) Br. J. Cancer 72, 1151–1159.
Vintetmyr, O.K., Boe, R, Brustugun, O.T., Maronde, E., Aakvaag, A. and Doskeland S.O. (1995) Endocrinology 136, 2513–2520.
Rohlff, C. and Glazer, R.I. (1995) Cell Signal 7, 431–443.
Bianco, C., Tortora, G., Baldassarre, G., Fontanini, G., Chine, S., Bianco, A.R. and Ciardiello, F. (1997) Clin. Cancer Res. 3, 439–448.
Tortora, G., Ciardiello, F., Pepe, S., Tagliaferri, P., Ruggiero, A., Bianco, C., Guarrasi, R., Mild, K. and Bianco, A.R. (1995) Clin. Cancer Res. 1, 377–384.
Srivastava, R.K, Srivastava, A.R. and Cho-Chung, Y.S. (1998) Clin. Cancer Res. 4, 755–763.
Ciardiello, F. and Tortora, G. (1998) Clin. Cancer Res. 4, 821–828.
Cvijic, M.E. and Chin, K.V. (1998) Biochem. Biophys. Res. Commun. 249, 723–727.
Chu, E., Johnston, P.G., Grem, J.L., Takimoto, C.H., Van Groeningen C., Chabner, B.A. and Allegra, C.J. (1994) Cancer Chemother. Biol. Response Modif. 15, 1–31.
O’Dwyer, P.J., Moyer, J.D., Suffness, M., Harrison, S.D. Jr. Cysyk, R., Hamilton, T.C. and Plowman, J. (1994) Cancer Res. 54, 724–729.
Tew, K.D., Colvin, M. and Chabner, B.A. (1996) in Cancer chemotherapy and Biotherapy (Chabner B.A. and Longo D.L., eds) Vol. 12, pp 297–332, Lippincott-Raven Publishers, Philadelphia, PA.
Friedman, H.S., Averbuch, S.D. and Kurtzberg, J. (1996) in Cancer chemotherapy and Biotherapy(Chabner B.A. and Longo D.L., eds) Vol. 13, pp 333–356, Lippincott-Raven Publishers, Philadelphia, PA.
Plooy, A.C.M., van Dijk, M. and Lohman, P.H.M. (1984) Cancer Res. 44, 2043–2051.
Kelland, L.R. (1993) Crit. Rev. Oncol. Hematol. 15, 191–219.
Stubbe, J. and Kozarich, J.M. (1987) Chem. Rev. 87, 1107–1136.
Corbett, A.H. and Osheroff N. (1993) Chem. Res. Toxicol. 6, 585–597.
Sinha, B.K (1995) Drugs 49, 11–19.
Hamilton, T.C., O’Dwyer, P.J. and Ozols, R.F. (1993) Curr. Opin. Oncol. 5, 1010–1016.
Fink, D., Nebel, S., Aebi, S., Zheng, H., Cenni, B., Nehme, A., Christen R.D. and Howell, S.B. (1996) Cancer Res. 56, 4881–4886.
Extra, J.M., Marty, M., Brienza, S., Misset, J.L. (1998) Semin. Oncol. 25, 13–22.
Cheson, B.D. (1992) Semin. Oncol. 19, 695–706.
Rodriguez G. (1994) Invest. New Drugs 12, 75–92.
Ignoffo, R.J. (1998) Cancer Pract. 6, 302–304.
Kaye S.B. (1998) Br. J. Cancer78, 1–7.
Kamen B. (1997) Semin. Oncol. 24, S18–30-S18–39.
Wall, M.E., Wani, M.C., Cook, C.E., Palmer, K.H., McPhail, A.T. and Sim, G.A. (1966) J. Am. Chem. Soc. 88, 3888–3890.
Wang, J.C. (1991) J. Biol. Chem. 266, 6659–6662.
Covey, J.M., Jaxel, C., Kohn, K.W. and Pommier, Y. (1989) Cancer Res. 49, 5016–5022.
D’Arpa, P., Beardmore, C. and Liu, L.F. (1990) Cancer Res. 50, 6919–6924.
Hsiang, Y.H., Lihou, M.G. and Liu, L.F. (1989) Cancer Res. 49, 5077–5082.
Tsao, Y.P., Russo, A., Nyamuswa, G., Silber, R. and Liu, L.F. (1993) Cancer Res. 53, 5908–5914.
Liu, W. and Zhang, R. (1998) Int. J. Oncol. 12, 793–804.
Gottlieb, J.A., Guarino, A.M., Call, J.B., Oliverio, V.T. and Block, J.B. (1970) Cancer Chemother. Rep. 54, 461–470.
Houghton, P.J., Cheshire, P.J., Myers, L, Stewart, C.F., Synold, T.W., Houghton, J.A. (1992) Cancer Chemother. Pharmacol. 31, 229–239.
Kawato, Y., Furuta, T., Aonuma, M., Yasuoka, M., Yokokura, T. and Matsumoto, K (1991) Cancer Chemother. Pharmacol. 28, 192–198.
Giovanella, B.C., Stehlin, J.S., Wall, M.E., Wani, M.C., Nicholas, A.W., Liu, L.F., Silber, R. and Potmesil, M. (1989) Science 246, 1046–1048.
Herben, V.M.M., ten Bokkel Huinink, W.W., Schellens, J.H.M., Beijnen J.H. (1998) Pharm. World Sci. 20, 161–172.
Rothenberg, M.L. (1997) Ann. Oncol. 8, 837–855.
Hyman, A. and Sorger, P. (1995) Annu. Rev. Cell De v. Biol. 11, 471–495.
Hunt, D.T., Jamison, T.F. and Schreiber, S.L. (1996) Chem. Biol. 3, 623–639.
Hamel, E. (1992) B. Pharmac. Ther. 55, 31–35.
Smith, C.D., Zhang, X., Mooberry, S.L., Patterson, G.M.L. and Moore, R.E. (1994) Cancer Res. 54, 3779–3784.
Wilson, L. and Jordan, M.A. (1995) Chem. Biol. 2, 569–573.
Kalechman, Y., Shani, A., Dovrat, S., Whisnant, J.K, Mettinger, K, Albeck, M. and Sredni, B. (1996) J. Immuno1. 156, 1101–1109.
Bollag, D.M., McQueney, P.A., Zhu, J., Hensens, O., Koupal, L., Liesch, J., Goetz, M.X., Lazarides, E. and Woods, C.M. (1995) Cancer Res. 55, 2325–2333.
Jordan, M.A., Toso, J.R., Thrower, D. and Wilson, L. (1993) Proc. Natl. Acad. Sci. USA 90, 9552–9556.
Wood, C.M., Zhu, J., McQueney, P.A., Bollag, D. and Lazarides, E. (1995) Mol. Med. 1, 506–526.
Shen, S.C., Huang, T.S., Jee, S.H. and Kuo, M.L. (1998) Cell Growth Differ. 9, 23–29.
Meijer, L. (1996) Trends in Cell Biology 6, 393–397.
Gray, N.S., Wodicka, L., Thunnissen, A.M.W.H., Norman, T.C., Kwon, S., Espinoza F.H., Morgan, D.O., Barnes, G., LeClerc, S., Meijer, L., Kim, S.H., Lockhart, D.J. and Schultz, P.G. (1998) Science 281, 533–538.
Senderowicz, A.M., Headlee, D., Stinson, S.F., Lush, R.M., Kalil, N., Villalba, L, Hill, K., Steinberg, S.M., Figg, W.D., Tompkins, A., Arbuck, S.G. and Sausville E.A. (1998) J. Clin.. Oncol. 16, 2986–2999.
Kaur, G., Stetler-Stevenson, M., Sebers, S., Worland, P., Sedllacek, H., Myers, C., Czech, J., Naik, R. and Sausville, E. (1992) J. Natl. Cancer Inst. 84, 1736–1740.
Worland, P.J., Kaur, G., Stetler-Stevenson, M., Sebers, S., Sartor, O. and Sausville, E.A. (1993) Biochem. Pharmacol. 17, 1831–1840.
Carlson, B.A., Dubay, M.M., Sausville, E.A., Brizuela, L. and Worland, P.J. (1996) Cancer Res. 56, 2973–2978.
Patel, V., Senderowicz, A.M., Pinto, D., Igishi, T., Raffeld, M., Quintanilla-Martinez, L., Ensley, J.F., Sausville, E.A. and Silvio Gutkind, J. (1998) J. Clin. Invest. 102, 1674–1681.
Arguello, F., Alexander, M., Sterry, J.A., Tudor, G., Smith, E.M., Kalavar, N.T., Greene, J.F. Jr., Koss, W., Morgan, C.D., Stinson, S.F., Siford, T.J., Alvord, W.G., Klabansky, R.L. and Sausville, E.A. (1998) Blood 91, 2482–2490.
Konig, A., Schwartz, G.K., Mohammad, R.M., Al-Katib, A. and Gabrilove, J.L. (1997) Blood 90, 4307–4312.
Bible, K.C. and Kaufmann, S.H. (1997) Cancer Res. 57, 3375–3380.
Hawking, F. (1978) Adv. Phamacol. Chemother. 15, 289–322.
Williams, L.T., Tremble, P.M., Lavin, M.F. and Sunday, M.E. (1984) J. Biol. Chem. 259, 5287–5294.
Coffey, R.J., Leof, E.B., Shipley, G.D. and Moses, H.L. (1987) J.Cell. Physiol. 132, 143–148.
Presta, M., Tiberio, L., Rustani, M., Dell’Era, P. and Ragnotti G. (1991) Cell Regul. 2, 719–726.
Cardinali, M., Sartor, O. and Robbins, KC. (1992) J. Clin. Invest. 89, 1242–1247.
Zhang, Y.L., Keng, Y.F., Zhao, Y., Wu, L. and Zhang, Z.Y. (1998) J. Biol. Chem. 273, 12281–12287.
Mahoney, C.W., Azzi, A. and Huang, K.P. (1990) J. Biol. Chem. 265, 5424–5428.
Bijanowski, K., Nishio, K., Fukuda, M., Larsen, A.K. and Saijo, N. (1994) Biochem. Biophys. Res. Commun. 203, 1574–1580.
Kopp, R. and Pfeiffer, A. (1990) Cancer Res. 50, 6490–6496.
De Clercq, E. (1979) Cancer Lett. 8, 9–22.
Jindal, H., Anderson, C., Davis, R. and Vishwanatha, J. (1990) Cancer Res. 50, 7754–7757.
Ono, K, Nakane, J. and Fukushima, M. (1988) Eur. J. Biochem. 172, 149–153.
Bojanowski, K., Lelievre, S., Markovits, J., Couprie, J., Jacquemin-Sablon, A. and Larsen, A.K (1992) Proc. Natl. Acad. Sci. USA 89, 3025–3029.
Taylor, M.F., Bhattacharyya, A.K and Collins, D.C. (1995) Steroids 60, 452–456.
Cadene, M., Duranton, J., North, A., Si-Tahar, M., Chignard, M. and Bieth, J.G. (1997) J. Biol. Chem. 272, 9950–9955.
Stein, C.A. (1993) Cancer Res. 53, 2239–2248.
Dawson, N., Figg, W.D., Brawley, O.W., Bergan, R., Cooper, M.R., Senderowicz, A., Headlee, D., Steinberg, S.M., Sutherland, M., Patronas, N., Sausville, E., Linehan, W.M. and Sartor, O. (1998) Clin. Cancer Res. 4, 37–44.
Omura, S., Iwai, Y., Hirao, A., Nakagawa, A., Awaya, J., Tsuchiya, H., Takahashi, Y. and Masuma, R. (1977) Antibiot. 30, 275–281.
Seynaeve, C.M., Kazanietz, M.G., Blumberg, P.M., Sausville E.A. and Worland P.J. (1994). Mol. Pharmacol. 45, 1207–1214.
Jones, T., Courage, C., Hubbard, A. and Gescher, A. (1997) Biochem. Pharmacol. 15, 1413–1418.
Gadbois, D.M., Hamaguchi, J.R., Swank, R.A. and Bradbury, E.M. (1992) Biochem. Biophys. Res. Commun. 184, 80–85.
Begemann, M., Kashimawo, S.A., Heitjan, D.F., Schiff, P.B., Bruce, J.N. and Weinstein, I.B. (1998) Anticancer Res. 18, 2275–2282.
Akiyama, T., Yoshida, T., Tsujita, T., Shimizu M., Mizukami, T., Okabe, M. and Akinaga, S. (1997) Cancer Res. 57, 1495–1501.
Nishi, K., Schnier, J.B. and Bradbury, E.M. (1998) Exp. Cell Res. 243, 222–231.
Schnier, J.B., Nishi, K., Godrich, D.W. and Bradbury, E.M. (1996) Proc. Natl. Acad. Sci. USA 93, 5941–5946.
Akinaga, S., Gomi, K, Morimoto, T. and Okabe, M. (1991) Cancer Res. 51, 4888–4892.
Janss, A.J., Levow, C., Bernhard, E.J, Muschel, R.J., McKenna, W.G., Sutton, L. and Phillips, P.C. (1998) Exp. Cell Res. 243, 29–38.
Utz, I., Hofer, S., Regenass, U., Hilbe, W., Thaler, J., Grunicke, H. and Hofmann, J. (1994) Int. J. Cancer 57, 104–110.
Lock, R.B., Thompson, B.S., Sullivan, D.M. and Stribinskiene, L. (1997) Cancer Chemother. Pharmacol. 39, 399–409.
Coradini, D., Biffi, A., Costa, A., Pellizzaro, C., Pirronello, E. and Di Fronzo, G. (1997) Cell Prolif. 30, 149–159.
Dyson, J.E.D., Daniel, J. and Surrey, C.R. (1992) Br. J. Cancer 65, 803–808.
Dong, Q.G., Gong, L.L., Wang, H.J. and Wang, E.Z. (1993) Anti-Cancer Drugs 4, 617–627.
Friend, C., Zajac-Kaye, M., Holland, J.G. and Pogo, B.G.T. (1987) Cancer Res. 47, 378–382.
Hennebery, R.C. and Fishman, P.H. (1976) Exp. Cell Res. 103, 55–62.
Kijima, M., Yoshida, M., Sugita, K, Horinouchi, S. and Beppu, T. (1993) J. Biol. Chem. 268, 22429–22435.
Gupta, S., Alpini, G., Vemuru, R.P., Hurston, E. and Shafritz, D.A. (1994) Growth Factors 10, 171–180.
Mandat, M., Wu, X. and Kumar, R. (1997) Carcinogenesis 18, 229–232.
Mandai, M. and Kumar R. (1996) Cell Growth Differ. 7, 311–318.
Riggs, M.G., Whittaker, R.G., Neumann, J.R. and Ingram, V.M. (1977) Nature (London) 268, 462–464.
De Haan, J.B., Gevers, W. and Parker, M.I. (1986) Cancer Res. 46, 713–716.
Hebbes, T.R., Thome, A.W. and Crane-Robinson, C. (1988) EMBO J. 7, 1395–1402.
Toscani, A., Soprano, D.R. and Soprano, K.J. (1988) Oncogene Res. 3, 223–238.
Tichonicky, L., Kruh, J. and Defer, N. (1990) Biol. Cell 69, 65–67.
Rousseau, D., Khochbin, S., Gorka, C. and Lawrence, J.J. (1992) Eur. J. Biochem. 208, 775–779.
Scharwtz, B., Avivi-Green, C. and Polak-Charcon S. (1998) Mol. Cell Biochem. 188, 21–30.
Archer, S.Y., Meng, S., Shei, A. and Hodin, R.A. (1998) Proc. Natl. Acad. Sci. USA 95, 6791–6796.
Heruth, D.P., Zirnstein, G.W., Bradley, J.F. and Rothberg, P.G. (1993) J. Biol. Chem. 268, 20466–20472.
Gope, R. and Gope, M.L. (1993) Cell Mol. Biol. 39, 589–597.
Miller, A.A., Kurschel, E., Osieka, R. and Schmidt, C.G. (1987) Eur. J. Clin. Oncol. 23, 1283–1289.
Pouillart, P.R. (1998) Life Sci. 63, 1739–1760.
Conley, B.A., Egorin, M.J., Tait, N., Rosen, D.M., Sausville, E.A., Dover, G., Fram, R.J. and Van Echo, D.A. (1998) Clin. Cancer Res. 4, 629–634.
Napoli J.L. (1990) In Chemistry and Biology of retinoic acid. (Dawson, M.I. and Okamura, H., eds.) pp. 229–249 CRC Press, Boca Raton, FL
de The, H., Vivanco-Ruiz, M., Tiollais, P., Stunnenberg, H. and Dejean, A. (1990) Nature, 343, 177–183.
Amos, B. and Lotan R. (1990) Methods Enzymol. 190, 217–225.
Parkinson, D.R., Smith, M.A., Cheson, B.D., Stevenson, H.C. and Friedman, M.A. (1992) Semin. Oncol. 19, 734–741.
Muindi, J., Frankel, S.R., Miller, W.H. Jr., Jakubowski, A., Scheinberg, D.A., Young, C.W., Dmitrovsky, E. and Warrell, R.P. Jr. (1992) Blood 79, 299–303.
Moore, D.M., Kalvakolanu, D.V., Lippman, S.M., Kavanagh J.J., Hong, W.K, Borden, E.C., Paredes-Espinoza, M. and Krakoff, I.H. (1994) Semin. Hematol. 31, 31–37.
Delia, D., Aiello, A., Lombardi, L., Pelicci, P.G., Grignani, F., Formelli, F., Menard, S., Costa, A., Veronesi, U. and Pierotti, M.A. (1993) Cancer Res. 53, 6036–66041.
ElAttar, T.M.A. and Lin, H.S. (1991) Prostaglandins Leukot. Essent. Fatty Acids 43 175–178.
Fontana, J.A., Reppuci, A., Durrham, J.P. and Miranda, D. (1986) Cancer Res. 46, 2468–2473.
Berdel, W.E., Bausert, W.R.E., Fink, V., Rastetter, J. and Munder P.J. (1981) Anticancer Res. 1, 345–352.
Storme, G., Berdel, W.E., Bruyneel, R., De Bruyne, G. and Mareel, M. (1983) Proc. Am. Assoc. Cancer Res. 24, 31.
Hochhut, C., Berkovic, D., Eibl, H.J., Unger, C. and Doenecke, D. (1990) J. Cancer Res. Clin. Oncol. 116, 459–466.
Harleman J.H. (1994) Drugs Today 30, 43–46.
Beckers T. and Voegeli, R. (1994) Drugs Today, 30, 13–20.
Uberall, F., Oberhuber, H., Maly, K., Zaknun, J., Demuth, L. and Grunicke, H.H. (1991) Cancer Res. 51, 807–812.
Berkovic, D., Goeckenjan, M., Luders, S., Hiddemann, W. and Fleer, E.A. (1996) J. Exp. Ther. Oncol. 5, 302–311.
Geilen, C.C., Wieder, T. and Reutter, W. (1992) J. Biol. Chem. 267, 6719–6724.
Wieder, T., Orfanos, C.E. and Geilen C.C. (1998) J. Biol. Chem. 273, 11025–11031.
Dummer, R, David, M. and Burg, G. (1994) Drugs Today, 30, 73–81.
Hilgard, P., Klenner, T., Stekar, J., Nossner, G., Kutscher,B. and Engel, J. (1997) Eur. J. Cancer 33, 442–446.
Wood, P.A. and Hrushesky, W.J. (1996) Crit. Rev. Eukaryot. Gene Exp. 6, 299–343.
Hrushesky, W. J. M. (editor), (1994) Circadian Cancer Therapy, pp 292, (12 chapters), CRC Press, London.
Ishikawa, F. (1997) Biochem. Biophys. Res. Commun. 230, 1–6.
Hale, A.J., Smith, C.A., Sutherland, L.C., Stoneman, V.E.A., Longthome, V.L., Culhane, A.C. and Williams, G.T. (1996) Eur. J. Biochem. 236, 1–26.
Folkman, J. (1995) New Engl. J. Med. 233, 1757–1763.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Damiens, E. (2000). Molecular events that regulate cell proliferation: an approach for the development of new anticancer drugs. In: Meijer, L., Jézéquel, A., Ducommun, B. (eds) Progress in Cell Cycle Research. Progress in Cell Cycle Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4253-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4253-7_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6909-7
Online ISBN: 978-1-4615-4253-7
eBook Packages: Springer Book Archive